Health Archive » June, 2025

Health - June, 2025

378 articles

• Cooley Advises Capstan In Sale To AbbVie Worth Up To $2.1B
• Allergan Botox Patent Fight Headed To July Trial In Del.
• Tillis, Senate IP Leader, Announces Retirement
• NC Insurance Agents Say Contract Is 'Unconscionable'
• Conn. Expects Corporate Tax Changes To Raise Almost $350M
• Texas Panel Says Suit Challenging Abortion Travel Is Unripe
• Catching Up With Delaware's Chancery Court
• Justices Won't Disturb 10th Circ. Oklahoma PBM Law Ruling
• DOJ Says Over 300 Charged In $14.6B Healthcare Fraud Sting
• Rite Aid Cleared To Sell Thrifty Ice Cream For $19.2M In Ch. 11
• 4th Circ. Won't Rethink Tossed Pregnancy Bias Suit
• Anthem, Blue Cross Sue Ga. Co. Over Alleged Insurance Scam
• Justices Decline Appeal Over State Law Question Certification
• Court Tosses Challenge To Nebraska Medical Pot Legalization
• Prepping For SEC's Changing Life Sciences Enforcement
• Adapting To Private Practice: From US Rep. To Boutique Firm
• Healthcare Co.'s $120K Wage Deal Rejected
• IRS Should Work With Industry On Microcaptive Regs
• High Court Turns Away Fired Christian Workers' Vax Bias Case
• Trump Administration Says Harvard Violated Civil Rights Law
• Justices Undo Patients' Win In Gender-Affirming Care Fight
• Justices Won't Eye Claim Fed. Circ. Revived Waived Argument
• Feds Prevail Over J&J In Another 340B Rebate Dispute
• DC Circ. Backs NLRB Ruling In GWU Hospital Bargaining Case
• Sam's Club Lifting Work Caused Miscarriage, Ex-Worker Says
• Patient Monitoring Co. To Pay Feds $1.3M To Settle FCA Suit
• Judge Lets DOGE Access Go On But Cites 'Grave' Concerns
• Feds Say Transnational Crime Ring Stole $10B From Medicare 
• After Dobbs, States Become Battleground For Abortion Rights
• Pregnancy Loss Draws Police Scrutiny Following Dobbs
• Full 5th Circ. To Hear Planned Parenthood Atty Immunity Row
• How Providers Can Brace For Drug Pricing Policy Changes
• Discretionary Denial Rulings May Spur Calls For PTAB Reform
• Rite Aid Picks $19.2M Bid For Thrifty Ice Cream In Ch. 11
• Contractor Must Face OT Suit Over Fringe Benefits Payments
• DC Judge Says Teen Health Projects Can 'Shutter' Temporarily
• MoFo, Latham Lead Medical AI Co. Carlsmed's $100M IPO
• Spinoff Transaction Considerations For Biotech M&A
• Virginia Medical Lab Denied Sales Tax Break For Reagents
• 3 DOL Policy Shifts On Benefits Attys' Radar
• NC Biz Court Bulletin: Last-Minute Settlements Head Off Trials
• Justices Salvage FCC Subsidy Fees, Reversing 5th Circ.
• Justices Back Task Force That Sets ACA Care Requirements
• Justices Limit Universal Injunctions But Defer On Citizenship
• Teladoc Can't Shake Most Of Suit Over Meta Pixel Data Sharing
• Phillip Morris Moves To Arbitrate Rivals' Tobacco Deal Suit
• Nurse Wins $27M In Retaliation Case Against Dignity Health
• Flaws In Expert Report Doom Mass. Suit Over Patient's Death
• Fla. Lawyers Suspended For Online Criticism Of Judge
• Hims & Hers Face Investor Suits Over Wegovy Collab
• Biotech Co. Must Face Investor Suit Over Misleading Claims
• UHC Accused Of Withholding $2M In Claims From NC Provider
• 6th Circ. Backs Mich. Newborn Blood Testing Program
• Kimberly-Clark Inks $4.15M Deal In Gown Fraud Suit
• Debunking 4 Misconceptions Around Texas' IV Therapy Law
• Ga. Panel Affirms $6.5M Verdict, $1.8M Fees Over Brain Injury
• Senate's 41% Litigation Finance Tax Would Hurt Legal System
• Psychedelic Treatment Regs May Be At A Tipping Point
• Ex-FDA Regulator Joins ArentFox Schiff's Pharma Practice
• Former Hoops Star Telfair Gets 6 Mos. For Violating Release
• NC Pathology Lab Patient Drops Data Breach Class Action
• Performing As A Clown Makes Me A Better Lawyer
• Justices Say SC Medicaid Patient Can't Sue To Pick Provider
• TCPA Litigants Brace For 'Seismic Shift' After Deference Blow
• Cigna Says Bristol-Myers Delayed Cancer Drug Generic
• OTC Pills Are Opioid In Disguise, Consumer Says
• Anti-Aging Biotech Startup Minovia Inks $180M SPAC Merger
• Michigan Man Gets 2 Years In 'Despicable' Pill, Fraud Scheme
• Late Conn. Doc's Estate To Defend Insemination Fraud Cases
• Feds Say Vet Failed To Back VA Malpractice Claim At Trial
• Ohio Judge Halts Insurance Broker's Biz Amid AG's Fraud Suit
• Trans Worker Says Metal Co.'s Health Plan Discriminatory
• CVS Fights Ruling In Del. Rejecting Coverage For Opioid Suits
• Focusing On Fluoride: From FDA To Class Action
• Hospital Slams Novo Nordisk's Insulin Pen Suit Sanctions Bid
• CVS PBM Hit With $95M Judgment For Overbilling Medicare
• K&L Gates Adds Powers Pyles Pharma Litigator To DC Team
• Law School's Missed Lessons: Rejecting Biz Dev Myths
• How An Ex-AUSA's Compliance Savvy Ended A Kickback Case
• Arkansas Insurance Dept. Fights Teamsters Plan's ERISA Suit
• Fla. Nonprofit Leaders Charged In $100M Fraud Scheme
• Minn. Water Co. Prevails In Retained Limit Coverage Row
• Health Data Co. Must Face Revised Investor Fraud Suit
• 4th Circ. Tosses Trans Man's Appeal Over Canceled Surgery
• Abbott Hit With Genetic Privacy Suit Over Hiring Practices
• Medical Pot Backers Urge Neb. High Court To Scrap Challenge
• Medline Can't Get $2.4M Tax Incentive, Wash. Panel Affirms
• Calif. AG Asks 9th Circ. To Undo Limits On Pay-For-Delay Ban
• AI Healthcare Startup Abridge Raises $300M Series E
• Ga. Justices Hold Off On Considering Wrongful Death Cap
• Pa. Tax Ruling Boosts Nonprofits' Competitive Edge, Attys Say
• Trump Admin Must Release NIH Funds Amid Appeal
• Cataract Surgery Tech Co. Secures $125M Series B Funding
• 10th Circ. Rejects Ex-GC's Sanctions Bid Against Loeb & Loeb
• A Midyear Review: Healthcare Dealmaking Trends Of 2025
• Move Beyond Surface-Level Edits To Master Legal Writing
• How Ore. Law Puts New Confines On Corp. Health Ownership
• Florida Judge Denies Bid To DQ Boies Schiller In Fee Suit
• Palantir Reaches Deal With Ex-Employees In AI Secrets Case
• Teladoc Says Investor Suit Over User Losses Is 'Illogical'
• Ga. Doctor On $2M Hook For Decapitated Baby Instagram Posts
• Ontrak Founder Gets 3½ Years In Novel Insider Trading Case
• 9th Circ. Sends Minor's Rehab Claim Back To Premera
• Handling Revenue Cycle Management Disputes In The AI Age
• Aflac Hit With Data Breach Class Action In Ga.
• Illumina To Buy SomaLogic For Up To $425M
• Medical AI Co. Says Rival Targeted 'Crown Jewel' Source Code
• 9th Circ. Has Muddied Waters Of Article III Pleading Standard
• Justices Skip Pa. Med Mal Fund's Bid To Shield $300M Surplus
• Science Research Funding Cuts Blocked By Mass. Judge
• High Court Urged To Rein In FDA Oversight Of Stem Cells
• Ga. Panel Says Suit To Collect $12.1M Judgment Too Late
• Healthcare Suit Financer Faces New Suit Over Data Breach
• DEA Judge Backs Federal Ban On 2 Research Chemicals
• 2nd Purdue Plan Heading For Creditor Vote, Nov. Hearing
• Investor Can't Get Emergency Injunction In Sinovac Battle
• UK Litigation Roundup: Here's What You Missed In London
• Texas Panel Blocks San Antonio's Abortion Travel Funding
• Trump Antitrust Shift Eases Pressure On Private Equity Deals
• PE Firm Demands FDA Docs For Defense In Deal Challenge
• Trump Taps Atty Dropped By Biden For Eastern Ky. Fed. Court
• Competing In Modern Pentathlon Makes Me A Better Lawyer
• 3rd Circ. Deems Immunity Defense Premature For Jailers
• Nose Spray Co. Sues FTC Over Substantiation Requirement
• Aflac Hacked In 'Campaign' Against Insurance Industry
• Boies Schiller Fights DQ Bid In Law Firms' Fee Dispute
• Taxation With Representation: Latham, Paul Weiss, Covington
• Law School Escapes Prof's Long-COVID Retaliation Suit
• Psychedelic Therapy Reform Gets Boost From Conservatives
• High Court Says FCC Orders Not Above District Court Review
• 4 ERISA Cases To Watch In The 2nd Half Of 2025
• Texas Judge Vacates Biden-Era HHS Abortion Privacy Rule
• Ga. Panel Affirms Emory's Early Win In Neonatal Care Suit
• J&J Hit With $8M Verdict In Multi-Exposure Talc Case
• Sotera Investors Urge 6th Circ. To Reopen Toxic Gas Suit
• Spectrum Pharma Investors Get First OK For $16M Deal
• NC Panel Rejects HCA Unit's Appeal Over Rival Project Award
• Psychedelics And The Law In Focus At Colo. Conference
• Nurse Staffing Exec Can't Nix Conviction, Sanctions Floated
• High Court Concurrences Signal Hard Battle For Trans Rights
• NY High Court Lifts Block On NYC Shifting Retiree Healthcare
• Ex-Drug Exec Must Testify, But Keeps 5th Amendment Rights
• FDA Dodges Suit Over Ozempic, Wegovy Listing
• DC Judge Restores Some Canceled COVID Grants For Now
• Prepare For Increased FDA Inspections Of Foreign Facilities
• Senate Panel Sets Vote On Trump Nominees For EEOC, DOL
• Tarter Krinsky Brings Back Healthcare And Pharmacy Chair
• Law School's Missed Lessons: Teaching Yourself Legal Tech
• DC Judge Throws Out Suits Over J&J Drug Discount Audits
• Eversheds Sutherland Adds Ex-Kelley Drye Restructuring Atty
• InnovAge IPO Investors Get Initial OK Of $27M Settlement
• Squire Patton Adds Polsinelli Trio To New Private Credit Group
• Supreme Court Upholds Tennessee Transgender Care Ban
• Chinese Co. Draws Fla. AG Probe Over Health Device Security
• Cancer Diagnostics Firm, Insurer Price 2 IPOs Totaling $902M
• Novo Nordisk Settles TM Suit Against Clinic Over Compounds
• 5 Court Battles Hinging On High Court's Trans Care Ruling
• NJ Court Says Unqualified Expert Dooms Med Mal Suit
• Ga. Panel Considers New Statute In $46M Med Mal Case
• Medical Documents Fair Game In STD Suit, Ga. Panel Says
• Health Insurance Co. Owes Workers OT Wages, Suit Claims
• HHS Says Trump Orders Merit Ending Trans Health Rule Case
• David Protein Avoids Court Ordered Ingredient Sale For Now
• Legacy Of 3 Justices Should Guide Transgender Rights Ruling
• Dexcom Faces TM Suit Over 'Stelo' Glucose Monitor Product
• FDA Unveils Voucher Program For Fast-Paced Drug Reviews
• Domestic Violence Groups Sue Feds Over Grant Restrictions
• 9th Circ. Backs Class Cert. In Suit Over Diabetes Drug Risk
• Ozempic, Wegovy Users Want NJ To Host Vision-Loss Suits
• How AI May Reshape The Future Of Adjudication
• Healthcare Worker's Wage Collective 'Amorphous,' HCA Says
• Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth
• WeightWatchers Cleared To Exit Ch. 11 And Cut $1.15B In Debt
• Medical AI Co. Calls Rival's Suit A Ploy To Kill Competition
• Kirkland-Led Lilly Inks $1.3B Deal For Cardio Drug Co. Verve
• When Legal Advocacy Crosses The Line Into Incivility
• Monsanto Fights Plaintiffs' Billion-Dollar Ask In PCB Tort Trial
• Doctor Will Admit Dealing Ketamine That Killed Matthew Perry
• Life Spine Accuses Ex-CEO Of Stealing Money, Trade Secrets
• US, UK Reach Trade Deal On Cars; Steel Tariffs Still Unresolved
• Pa. Court Revives Suit Over Patient's Bad Drug Reaction
• Cannabis Regulators Association Names New Board Members
• Lowe's Faces Worker Class Claims Over Tobacco Surcharge
• Ex-Fox News Host, Employee Agree To End Sex Assualt Case
• Ohio Tells 6th Circ. PBM Case Doesn't Target Federal Work
• How Medical Practices Can Improve Privacy Compliance
• HIV, AIDS Patients Denied Class Cert. In CVS Bias Fight
• Worker Asks 4th Circ. To Rethink Tossed Pregnancy Bias Suit
• King & Spalding Adds HHS Inspector General's Chief Counsel
• Mass. Judge Blocks NIH Grant Cuts, Points To 'Discrimination'
• All 50 States Agree To Purdue Pharma's $7.4B Settlement
• High Court Won't Revisit Landmark Religious Freedom Ruling
• Justices Turn Away Merck's Bone Drug Warning Label Row
• Justices Take Up NJ Anti-Abortion Group's Subpoena Fight
• 7th Circ. Won't Revive RICO Claims Against Blood Test Co.
• AbbVie Sues Colo. Over State Discount Drug Law
• Stewart Releases Flood Of Discretionary Denial Decisions
• Wash. Judge Tosses IUD Suit Against Bayer For Good
• More IPO Prospects Ready To Test Market After Chime's Debut
• Injunction Sought After J&J Unit's Catheter Antitrust Loss
• Health Tech Co. Overstated AI Capabilities, Investor Suit Says
• Recent Reports Shed Light On Section 340B's Effectiveness
• 5th Circ. Says No Private Right Of Action In No Surprises Act
• Jefferson Health Hit With Disability Bias Suit By Ex-Director
• DC Circ. Urged To Reject Approval For Braille-Free Drug Label
• Pa. Home Care Agency Owner Gets Prison, $235K Restitution
• Akerman Seeks To Move Malpractice Suits From Medical Cos.
• Midyear Report: 5 ERISA Decisions Attys Should Know
• AstraZeneca Inks Up To $5.3B AI Drug Deal With Chinese Firm
• CVS Wants To Halt Ark. Law Banning PBM-Owned Pharmacies
• $69M UnitedHealth 401(k) Deal Gets Green Light
• UK Litigation Roundup: Here's What You Missed In London
• Volunteering At Schools Makes Me A Better Lawyer
• 7th Circ. Backs Hartford's Denial Of Benefits To Ex-PwC Exec
• Arbitration Order Reversed In Fla. Medical Office Battery Case
• Holmes Seeks 2 Year Cut, Commits To Criminal Justice Work
• Florida, Sandoz Say They've Fixed Generic Drug Price-Fix Deal
• Fla. Doc Sues In Del. Alleging Multistate Group Conspiracy
• 'Forum Shopping' Center Stage At 6th Circ. Drug Pricing Args
• Insurer Says Hair Relaxer Maker Not Covered In Cancer Suits
• Humana, Aetna Underpaid For 340B Drugs, New Suits Say
• 5 Open Questions About FDA's AI-Assisted Review Plans
• DHS Tightens Rules On Info Disclosure, Medical Exam Validity
• How Trump Administration's Antitrust Agenda Is Playing Out
• Attacks On Judicial Independence Tend To Manifest In 3 Ways
• WWE Accuser's Firm Blames PACER For Late Response
• 5 Firms Guide $1.25B BioNTech, CureVac Oncology Deal
• Wis. Children's Hospital Denied Exemption For Hospital Tower
• Fed. Circ. Says VA Worker Must Submit To Random Drug Tests
• PTAB Issues Mixed Group Of Discretionary Denial Decisions
• Seattle Hospital Hit With Class Suit Over 'Diverted' Pain Meds
• RFK Jr. Picks Vaccine Critics As Part Of CDC Panel Overhaul
• UNC Hospital System Must Face Ex-Resident's Bias Suit
• IP, Health Law Scholars Object To 23andMe Ch. 11 Data Sale
• VA Contractor To Pay $4.3M To Resolve Overbilling Claims
• PepGen Faces Investor Suit Over Muscular Dystrophy Drug
• Children's Healthcare Nonprofit Settles Retirement Fee Suit
• Ga. Hospice Provider Pays $9.2M To End Kickback Case
• Aetna Resolves Lipedema Patients' Coverage Class Action
• Cigna Accused Of Misusing $17M In 401(k) Forfeitures
• Walmart Pharmacist Says Age, Disability Bias Led To Firing
• Conn. Orthopedic Practice Faces Data Breach Class Claims
• Health Network Strikes Deal In Retirement Plan Forfeiture Suit
• Oklahoma Pot Agency Wants Claims Tossed In Retaliation Suit
• Law School's Missed Lessons: Appreciating Civil Procedure
• Stewart's Newest Discretionary Denial Has Attys On Edge
• Ga. Justices Consider Tolling In Tongue Amputation Case
• States Sue To Block 23andMe From Selling DNA Data In Ch. 11
• IT Co. Urges 1st Circ. To Affirm It's Blameless For Data Breach
• Amazon Can't Duck Suit Over Non-FDA Approved Supplements
• Ala. Judge Orders Trans Health Org. To Publish Training Vids
• 9th Circ. Skeptical Oregon Hospital Merger Law Is Too Vague
• Health Records Co. Looks To Toss Patient Data Access Case
• Healthcare, Tech-Focused SPAC Prices $220M IPO
• Pandemic Law Doesn't Protect Mich. Hospital In Bedsore Case
• 3rd Circ. Upholds NFL Case Findings On Censured Atty
• Calif. Bar Exam Fiasco Shows Why Attys Must Disclose AI Use
• What Parity Rule Freeze Means For Plan Sponsors
• Judge Rebukes Navy Vet's Counsel In VA Malpractice Trial
• RFK Jr. Fires CDC's Entire 17-Member Vaccine Advisory Panel
• Trump Orders Targeting DEI, LGBTQ+ Funding Partly Blocked
• Okla. Says High Court Shouldn't Skip 10th Circ. PBM Ruling
• Veteran Appeals VA Discontinuation Of Trans Health Coverage
• Aetna Inks $3.4M Deal In Suit Over Cancer Treatment Denials
• Doc Says WWE Accuser's Firm Ignored Defamation Suit
• 'Substantial' Fraud Risk Keeps PruittHealth Breach Suit Alive
• Gov't Seeks $706M Penalty In FCA Case Against Omnicare, CVS
• 2nd Circ. Nixes Doc's Power Of Atty Deal In Patient ERISA Suit
• Sheppard Mullin Adds Perkins Coie IP Trio In DC, Chicago
• AI-Powered Cancer Diagnostics Firm Targets $400M IPO
• HI Gov. Eyes Veto Of Medical Pot Bill Over Privacy Concerns
• Rite Aid Gets Stay Of Appeals From Its Earlier Bankruptcy
• In 2nd Place, Va. 'Rocket Docket' Remains Old Reliable
• Boies Schiller Faces DQ Bid In Law Firms' Battle In Florida
• Bank Gets First Dibs On Bankrupt Pa. Nursing Homes' Coffers
• Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand
• Patent Office Leader Rejects IPRs Based On 12-Year Wait
• Tobacco Cos. Sue Philip Morris Over Bid To Void Wash. Deal
• Contract Board Says VA Must Pay $133K In Delivery Fees
• Circle's Smash IPO Could Pave Way For More Crypto Listings
• Texas Court Says Doctor Can Be Sued For Service Dog Mauling
• Justices Reject Eligibility Appeal On Telemedicine Patents
• J&J Unit's $147M Catheter Antitrust Loss Tripled To $442M
• Pharma Co. Trade Secrets Case Stays In Fla. Despite HQ Move
• Real Estate Recap: Hotels, Healthcare REITs, Secondaries
• Wash. Panel Grills Ambulance Co. On Crash Immunity Defense
• Rite Aid Emphasizes It Will Pay Rent To Objecting Landlords
• Texas AG Says Trans Care Investigation Is Lawful
• NJ Court Blocks LTC Insurer's Bid For Triple-Digit Rate Hike
• Judge Denies Class Cert. In Suit Over Unsolicited Faxes
• Fed. Circ. Weighs Purview Over Acorda's $17M Arbitral Award
• CVS Health Can't Dodge Blame In Omnicare False Claims Suit
• Free Speech Shields Rehab From Permit Suit, Court Says
• Aetna Seeks Quick Appeal In $20M Air Ambulance Billing Case
• Fla. Medical Billing Co. Accused Of Filing False Genetic Tests
• What FCA Liability Looks Like In The Cybersecurity Realm
• Boston Feds Must Do 'More With Less' On White Collar Front
• NJ Firm Says It Has No Business Being Sued In Louisiana
• Other Carrier Must Cover $1.1M Injury Award, Insurer Says
• How Attorneys Can Become Change Agents For Racial Equity
• Seton Hall Suit About Negligence, Not MedMal, Hoopsters Say
• Taxation With Representation: Winston, Stibbe, Weil, Goodwin
• Attys Seek $23M Cut Of $69M UnitedHealth 401(k) Settlement
• Greenberg Traurig Adds Perkins Coie Tech Transactions Pro
• 'Sparse' OPM Record On Mass Firings Backs Win, Unions Say
• Red States Double Down On Bid To Stymie Trans Health Rule
• Latham-Led Virtual Health Startup Omada Prices $150M IPO
• Sens. Float Automatic Biosimilar Interchangeable Label
• $1.36B Home Healthcare Deal Dropped Amid FTC Scrutiny
• Med Mal Juror Misconduct Claim Won't Mean New Trial
• 4 AGs Urge FDA To Lift Abortion Pill Restrictions
• Citi Let Hackers Bleed Med School Of Over $800K, Suit Says
• NJ High Court Will Review Injury Suits Against Walmart, Clinic
• CVS Sued Over Health Plan's Tobacco, Spousal Surcharges
• CMS Guidance May Complicate Drug Pricing, Trigger Lawsuits
• NC Pathology Practice Faces Class Claims Over Data Breach
• Mich. AG Asks Judge To Block Abortion Coercion Screening
• Ex-Bush Admin Atty To Lead HHS Civil Rights Office
• DOL Benefits Arm Needs Turnaround, Nominee Tells Senators
• Running Marathons Makes Me A Better Lawyer
• High Court Drops Class Cert. Clarification Bid
• Calif. Won't Get Insulin Pricing Case Sent Back To State Court
• 23andMe, Bidders Agree To Post-Ch. 11 Auction Offer Process
• USPTO Says Study Disproves Pharma Patent Thicket Claims
• 4th Circ. Invokes Rooker-Feldman In Hospitalization Case
• NC Biz Court Bulletin: TikTok Tussle And Merger Melee
• Copter Companies Will Pay $30M To 2 Estates For Fatal Crash
• 3 Ways DOL Benefits Chief Nominee May Affect ERISA Cases
• Heart Device Maker iRhythm Gets Investor Claims Trimmed
• Judge Halts Fla. Law Over Medicaid Ballot Initiative Concerns
• Novo Nordisk Wants Hospital Sanctioned For Insulin Pen Suit
• Nationwide Hit With Suit Over Dropped Pet Coverage
• 3 Takeaways From Recent Cyberattacks On Healthcare Cos.
• Mo. Appeals Court Upholds City Tax On REIT's Rental Income
• ITC Issues Import Ban In Dermatology Needle Patent Case
• Ga. Manufacturer Fired HR Exec For Reporting Bias, Suit Says
• DC Judge Weighs Harm In Teen Program Funding Fight
• Apple Can Shield Info In NJ TikTok Addiction Suit
• Vape Cos. Urge 5th Circ. To Toss FDA Vape Marketing Rule
• Ohio Nonprofit, Nursing Homes To Pay $3.6M To End FCA Suit
• Law School's Missed Lessons: Supporting A Trial Team
• Trump Admin. Nixes Guidance Protecting ER Abortion Care
• Pharma Group Can Pursue Challenge To Insulin Pricing Law
• Patent Deals Accelerate Access To Generics, Drug Group Says
• 6th Circ. Denies PBMs' Privilege Claim In Opioid MDL
• MultiPlan Must Face Reimbursement Pricing Antitrust MDL
• Plan Providers Must Face DOJ Overpayment Suit, Judge Says
• Adidas, UChicago Failed To Protect Data In Hacks, Suits Say
• InnovAge To Pay $27M To Resolve IPO Investors' Suit
• Canada Customers Agree To Halt 23andMe Data Breach Suits
• Feds Extend Pause On Fight Over Short-Term Insurance Regs
• Rosen, Pomerantz To Lead Seattle Biotech Class Action
• HHS, DOGE Accused Of Using Flawed Data In Mass Layoffs
• Latham Advises Atai In $390M Merger With Beckley Psytech
• Fla. Jury Finds CEO Guilty In $1.4B Medicare Fraud
• 2nd Circ. Says Social Worker Can't Challenge NY Abortion Law
• Simpson Thacher Adds Ex-Weil M&A Pro In NYC
• FAR Rewrite May Cloud Key Gov't Contract Doctrine
• The Law360 400: A Look At The Top 100 Firms
• Calif. Panel Won't Restore Subclasses In Nurses' Wage Suit
• Adapting To Private Practice: From US Attorney To BigLaw
• Katten Adds 4 Ex-Kirkland Attys To Healthcare Practice
• Pa. Panel Grants New Trial In Death Suit Against ER Doctor
• 9th Circ. Sends Express Scripts Opioid Case To State Court
• 23andMe Founder Pushes Alternative Ch. 11 Sale
• Ore. Psilocybin Access Suit Can Continue, Judge Says
• Del. Can't Escape Hospital's Challenge Of Cost Review Board
• Monthly Merger Review Snapshot
• Nursing Exec Says DOJ Misapplied Justices' Fraud Ruling
• Most-Favored Nation Drug Pricing Could Shake Up US Pharma
• Minn. Justices Prod Humana On Pharmacy Benefit Sourcing
• Judge Out Of Line In Undoing $1M LSD Verdict, 5th Circ. Told
• Allergan Entities Get Booted From Botox Patent Suit In Del.
• Conn. Hospital's $8.3M Bonus Claims Fail, State Says
• Foley & Lardner Opens In Nashville With 3 Holland & Knight Attys
• The Ins And Outs Of Consensual Judicial References
• KKR Plugs $600M Into Indian Medical Conglomerate
• Defamation Litigation Roundup: Cheetos, NASCAR, OpenAI